Young Teresa L.
Known title: See RemarksCIK: 0001814656
Associated companies
Transaction History
| MCRB | ▲ Buy | Option Exercise | 231 | — | 2/15/2026 | View on chart |
| MCRB | ▼ Sell | Open Market | 75 | $635 | 2/15/2026 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 132 | — | 11/15/2025 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 98 | — | 11/15/2025 | View on chart |
| MCRB | ▼ Sell | Open Market | 1,042 | $18K | 11/15/2025 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 3,998 | — | 11/15/2025 | View on chart |
| MCRB | ▼ Sell | Open Market | 59 | $982 | 8/18/2025 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 97 | — | 8/15/2025 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 133 | — | 8/15/2025 | View on chart |
| MCRB | ▼ Sell | Open Market | 63 | $459 | 5/16/2025 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 133 | — | 5/15/2025 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 98 | — | 5/15/2025 | View on chart |
| MCRB | ▼ Sell | Open Market | 3,338 | $3K | 2/18/2025 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 2,657 | — | 2/15/2025 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 7,813 | — | 2/15/2025 | View on chart |
| MCRB | ▼ Sell | Open Market | 735 | $398 | 11/18/2024 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 2,656 | — | 11/15/2024 | View on chart |
| MCRB | ▼ Sell | Open Market | 2,983 | $2K | 10/28/2024 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 11,360 | $0 | 10/27/2024 | View on chart |
| MCRB | ▼ Sell | Open Market | 728 | $612 | 8/16/2024 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 2,656 | — | 8/15/2024 | View on chart |
| MCRB | ▼ Sell | Open Market | 24,480 | $27K | 8/5/2024 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 85,000 | — | 8/3/2024 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 2,656 | — | 5/15/2024 | View on chart |
| MCRB | ▼ Sell | Open Market | 703 | $661 | 5/15/2024 | View on chart |
| MCRB | ▼ Sell | Open Market | 3,374 | $4K | 2/16/2024 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 10,625 | — | 2/15/2024 | View on chart |
| MCRB | ▼ Sell | Open Market | 2,907 | $4K | 10/30/2023 | View on chart |
| MCRB | ▲ Buy | Option Exercise | 11,361 | $0 | 10/27/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
MCRB to Present Preclinical Data on SER-428 at IDWeek 2026
Seres Therapeutics announced it will present preclinical data for SER-428, an investigational live biotherapeutic intended to reduce the risk of bloodstream infections in critically ill patients, at the upcoming IDWeek 2026 conference. The data will focus on early-stage results that support the development of the oral liquid LBP. The stock is currently trading near its $7.60 support level with an RSI of 22.8, indicating limited recent price momentum.
MCRB to Present Preclinical Data on SER-428 at IDWeek 2026. Seres Therapeutics announced it will present preclinical data for SER-428, an investigational live biotherapeutic intended to reduce the risk of bloodstream infections in critically ill patients, at the upcoming IDWeek 2026 conference. The data will focus on early-stage results that support the development of the oral liquid LBP. The stock is currently trading near its $7.60 support level with an RSI of 22.8, indicating limited recent price momentum.